M
Michel Kather
Researcher at University of Freiburg
Publications - 8
Citations - 54
Michel Kather is an academic researcher from University of Freiburg. The author has contributed to research in topics: Chemistry & Silicone. The author has an hindex of 4, co-authored 7 publications receiving 25 citations.
Papers
More filters
Journal ArticleDOI
Enzymatic spiroketal formation via oxidative rearrangement of pentangular polyketides.
Britta Frensch,Thorsten Lechtenberg,Michel Kather,Zeynep Yunt,Martin U. Betschart,Bernd Kammerer,Steffen Lüdeke,Michael Müller,Jörn Piel,Robin Teufel +9 more
TL;DR: In this article, a polycyclic aromatic precursor undergoes extensive enzymatic oxidative rearrangement catalyzed by two flavoprotein monooxygenases and a flavouroprotein oxidase that ultimately results in a drastic distortion of the carbon skeleton.
Journal ArticleDOI
Long-Term in vivo Release Profile of Dexamethasone-Loaded Silicone Rods Implanted Into the Cochlea of Guinea Pigs.
Arne Liebau,Sören Schilp,Kenneth Mugridge,Ilona Schön,Michel Kather,Bernd Kammerer,Jochen Tillein,Susanne Braun,Stefan K. Plontke +8 more
TL;DR: An effective dose range between 50 and 100 ng/ml after burst release is suggested for the CI insertion trauma model, and dexamethasone can be released from silicone electrode carrier dummies in a controlled and sustained way over a period of several weeks, leading to constant drug concentrations in the scala tympani perilymph.
Journal ArticleDOI
Unraveling altered RNA metabolism in pancreatic cancer cells by liquid-chromatography coupling to ion mobility mass spectrometry
Simon Lagies,Manuel Schlimpert,Lukas Braun,Michel Kather,Johannes Plagge,Thalia Erbes,Uwe A. Wittel,Bernd Kammerer +7 more
TL;DR: A method for modified nucleosides covering 37 species is reported that could discriminate different subtypes of pancreatic cancer cell lines and could clearly be separated from a pancreatic control cell line as well as blank medium.
Journal ArticleDOI
Metabolic Response to XD14 Treatment in Human Breast Cancer Cell Line MCF-7.
Daqiang Pan,Michel Kather,Lucas Willmann,Manuel Schlimpert,Christoph Bauer,Simon Lagies,Karin Schmidtkunz,Steffen U. Eisenhardt,Manfred Jung,Stefan Günther,Bernd Kammerer +10 more
TL;DR: XD14 is a 4-acyl pyrrole derivative, which was discovered by a high-throughput virtual screening experiment as mentioned in this paper, and it inhibits bromodomain and extra-terminal domain (BET) proteins (BRD2, BRD3 and BRD4) and consequently suppresses cell proliferation.
Journal ArticleDOI
A novel phosphocholine‐mimetic inhibits a pro‐inflammatory conformational change in C‐reactive protein
Johannes Zeller,Karen S. Cheung Tung Shing,Tracy L. Nero,James D. McFadyen,Guy Y. Krippner,B. Bogner,Sheena Kreuzaler,Jurij Kiefer,Verena K. Horner,David Braig,Habiba Danish,Sara Baratchi,Mark Fricke,Xiao-Wen Wang,Michel Kather,Bernd Kammerer,Kevin J. Woollard,Prerna Sharma,Craig J. Morton,Geoffrey A. Pietersz,Michael W. Parker,Karlheinz Peter,Steffen U. Eisenhardt +22 more
TL;DR: In this paper , a tool compound was designed as a low molecular weight CRP inhibitor using the structure of phosphocholine as a template, and in vitro and in vivo proof-of-concept data demonstrating that the tool compound inhibits CRP-driven exacerbation of local inflammatory responses, while potentially preserving pathogen-defense functions of CRP.